These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 2790794

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
    Teicher BA, Cucchi CA, Lee JB, Flatow JL, Rosowsky A, Frei E.
    Cancer Res; 1986 Sep; 46(9):4379-83. PubMed ID: 3731096
    [Abstract] [Full Text] [Related]

  • 3. Altered topoisomerase IIalpha and multidrug resistance-associated protein levels during drug selection: adaptations to increasing drug pressure.
    Matsumoto Y, Takano H, Nagao S, Fojo T.
    Jpn J Cancer Res; 2001 Sep; 92(9):968-74. PubMed ID: 11572765
    [Abstract] [Full Text] [Related]

  • 4. Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3.
    Cimoli G, Valenti M, Parodi S, Mazzoni A, De Sessa F, Conte P, Russo P.
    Oncol Res; 1993 Sep; 5(8):311-23. PubMed ID: 8012063
    [Abstract] [Full Text] [Related]

  • 5. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
    Vadi H, Drewinko B.
    Cancer Res; 1986 Mar; 46(3):1105-9. PubMed ID: 3080232
    [Abstract] [Full Text] [Related]

  • 6. Preclinical studies and clinical correlation of the effect of alkylating dose.
    Frei E, Teicher BA, Holden SA, Cathcart KN, Wang YY.
    Cancer Res; 1988 Nov 15; 48(22):6417-23. PubMed ID: 3180059
    [Abstract] [Full Text] [Related]

  • 7. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
    Schneider E, Horton JK, Yang CH, Nakagawa M, Cowan KH.
    Cancer Res; 1994 Jan 01; 54(1):152-8. PubMed ID: 7903202
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of DNA synthesis inhibitors on DNA methylation in normal and transformed cells.
    de Haan JB, Parker MI.
    Anticancer Res; 1988 Jan 01; 8(4):617-20. PubMed ID: 2845852
    [Abstract] [Full Text] [Related]

  • 9. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.
    Harker WG, Slade DL, Parr RL, Feldhoff PW, Sullivan DM, Holguin MH.
    Cancer Res; 1995 Apr 15; 55(8):1707-16. PubMed ID: 7712479
    [Abstract] [Full Text] [Related]

  • 10. Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cells.
    Lelièvre S, Benchokroun Y, Larsen AK.
    Mol Pharmacol; 1995 May 15; 47(5):898-906. PubMed ID: 7746278
    [Abstract] [Full Text] [Related]

  • 11. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
    Hamaguchi K, Godwin AK, Yakushiji M, O'Dwyer PJ, Ozols RF, Hamilton TC.
    Cancer Res; 1993 Nov 01; 53(21):5225-32. PubMed ID: 8106143
    [Abstract] [Full Text] [Related]

  • 12. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note.
    Kaufmann SH.
    Cancer Res; 1989 Nov 01; 49(21):5870-8. PubMed ID: 2790800
    [Abstract] [Full Text] [Related]

  • 13. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
    Kumar A, Soprano DR, Parekh HK.
    Cancer Res; 2001 Oct 15; 61(20):7552-5. PubMed ID: 11606393
    [Abstract] [Full Text] [Related]

  • 14. DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
    Long BH, Musial ST, Brattain MG.
    Cancer Res; 1986 Aug 15; 46(8):3809-16. PubMed ID: 3015377
    [Abstract] [Full Text] [Related]

  • 15. Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas.
    Bodell WJ, Gerosa M, Aida T, Berger MS, Rosenblum ML.
    Cancer Res; 1985 Aug 15; 45(8):3460-4. PubMed ID: 3860285
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo.
    Teicher BA, Holden SA, Eder JP, Brann TW, Jones SM, Frei E.
    Cancer Res; 1989 Nov 01; 49(21):5994-8. PubMed ID: 2790813
    [Abstract] [Full Text] [Related]

  • 18. Resistance to antitumor agent-induced apoptosis in a mutant of human myeloid leukemia U937 cells.
    Kataoka S, Naito M, Tomida A, Tsuruo T.
    Exp Cell Res; 1994 Nov 01; 215(1):199-205. PubMed ID: 7957669
    [Abstract] [Full Text] [Related]

  • 19. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors.
    Paz MF, Avila S, Fraga MF, Pollan M, Capella G, Peinado MA, Sanchez-Cespedes M, Herman JG, Esteller M.
    Cancer Res; 2002 Aug 01; 62(15):4519-24. PubMed ID: 12154064
    [Abstract] [Full Text] [Related]

  • 20. Augmentation of 1-beta-D-arabinofuranosylcytosine resistance in human KB epidermoid carcinoma cells upon induction of a second resistance to vincristine.
    Sone S, Ishii K, Tsuruo T.
    Cancer Res; 1986 Jun 01; 46(6):3099-104. PubMed ID: 3698026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.